Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Intra-Cellular Therapies Inc (NASDAQ:ITCI)

16.09
Delayed Data
As of 4:00pm ET
 +0.10 / +0.63%
Today’s Change
7.85
Today|||52-Week Range
22.67
+6.63%
Year-to-Date
2 Small Biopharmas With Case of 'Hiccups'
Oct 18 / TheStreet.com - Paid Partner Content
 

Today’s Trading

Previous close15.99
Today’s open15.95
Day’s range15.67 - 16.12
Volume363,052
Average volume (3 months)739,286
Market cap$849.1M
Dividend yield--
Data as of 4:00pm ET, 10/19/2017

Growth & Valuation

Earnings growth (last year)+7.56%
Earnings growth (this year)+13.10%
Earnings growth (next 5 years)--
Revenue growth (last year)+261.96%
P/E ratioNM
Price/Sales1,973.06
Price/Book1.84

Competitors

 Today’s
change
Today’s
% change
CYTKCytokinetics Inc-0.55-3.58%
AKAOAchaogen Inc+0.85+6.31%
RETAReata Pharmaceutical...-1.20-3.64%
AKBAAkebia Therapeutics ...-0.22-1.22%
Data as of 4:00pm ET, 10/19/2017

Financials

Next reporting dateNovember 8, 2017
EPS forecast (this quarter)-$0.62
Annual revenue (last year)$330.7K
Annual profit (last year)-$116.4M
Net profit margin-35,205.79%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Sharon Mates
CFO, Treasurer &
Vice President-Finance
Lawrence J. Hineline
Corporate headquarters
New York, New York

Forecasts